Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up 0.55% Nasdaq Up 0.29%
Streaming
Ticker Tape: On

More On NONOF

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates
  • Research Reports

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Novo Nordisk A/S (NONOF)

-Other OTC
43.85 0.25(0.57%) Apr 15, 3:11PM EDT
|Pre-Market : NaN
Get the big picture on all your investments.
Prev Close:44.10
Open:43.85
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:43.85 - 43.85
52wk Range:29.90 - 48.90
Volume:100
Avg Vol (3m):29,737
Market Cap:116.35B
P/E (ttm):27.02
EPS (ttm):1.62
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

ยป More Headlines for NONOF

Reports

  • No Reports available for NONOF at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):8.07
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More

Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback